N@N

Vincent Andrews Maintained (CC) at Hold with Decreased Target to $33 on, Oct 25th, 2022

Vincent Andrews of Morgan Stanley, Maintained "The Chemours Company" (CC) at Hold with Decreased Target from $41 to $33 on, Oct 25th, 2022.

Vincent has made no other calls on CC in the last 4 months.

There are 6 other peers that have a rating on CC. Out of the 6 peers that are also analyzing CC, 4 agree with Vincent's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Duffy Fischer of "Goldman Sachs" Initiated at Hold and Held Target at $30 on, Thursday, October 13th, 2022
• David Coleman of "Argus Research" Downgraded from Strong Buy to Hold on, Wednesday, October 5th, 2022
• Michael Leithead of "Barclays" Maintained at Hold with Decreased Target to $30 on, Tuesday, September 27th, 2022
• Joshua Spector of "UBS" Maintained at Hold with Increased Target to $37 on, Friday, July 29th, 2022

These are the ratings of the 2 analyists that currently disagree with Vincent

---

• John McNulty of "BMO Capital" Maintained at Buy with Decreased Target to $46 on, Friday, September 23rd, 2022
• Arun Viswanathan of "RBC Capital" Maintained at Buy with Decreased Target to $35 on, Thursday, September 22nd, 2022

Contributing Sources

---